Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by FerrariPalmbeacon May 17, 2017 10:00am
117 Views
Post# 26254208

Bank of America Merrill Lynch Presentations today>>>>>>>>>

Bank of America Merrill Lynch Presentations today>>>>>>>>>Presentations ARE TODAY @ Bank of America Merrill Lynch!!!!! Buy before these presentations. IMHO ! LAVAL, Quebec, May 10, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to present at the following health care conferences: Bank of America Merrill Lynch 2017 Healthcare Conference on Wednesday, May 17, 2017 at 3:00 p.m. PDT (6:00 p.m. EDT) at the Wynn Las Vegas hotel; UBS Global Healthcare Conference to be held on Monday, May 22, 2017 at 9:00 a.m. EDT at the Grand Hyatt New York hotel; and Jefferies 2017 Global Healthcare Conference to be held on Wednesday, June 7, 2017 at 8:30 a.m. EDT at the Grand Hyatt New York hotel. A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: https://ir.valeant.com/events-and-presentations
<< Previous
Bullboard Posts
Next >>